Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, has noted its position on the potential enactment of the Cannabis Administration and Opportunity Act. Senators Chuck Schumer (D-NY), Ron Wyden (D-OR) and Cory Booker (D-NJ) released a discussion draft of the act on July 14, 2021. As presented, the act would remove cannabis from the federal list of controlled substances, making cannabis use legal at the federal level. According to the company’s announcement, the act also enables states to implement their own adult-use recreational cannabis laws. Almost 20 states have already done that, including California, where Grapefruit is currently operating; in addition the District of Columbia, the northern Marianas Islands and Guam have adult-use cannabis laws. Even more states — 37 in total — have laws legalizing medical-use prescribed cannabis use. The summary of the discussion draft of the act states that more than 90% of Americans believe cannabis should be legal for adult recreational and medical use. “Grapefruit enthusiastically supports the efforts of Senators Schumer, Wyden and Booker to jumpstart the long-awaited removal of cannabis from the federal list of controlled substances,” said Grapefruit co-founder and CEO Bradley J. Yourist. “Passage of the ACT will accelerate our ability to offer Grapefruit’s patented, disruptive Hourglass(TM) time-release THC+cannabinoid delivery cream to all Americans whose states or territories of residence have legalized cannabis at the state or territorial level, thereby affording them the ability to enjoy the benefits of the Hourglass full-spectrum entourage experience. Once the ACT, as described in the discussion draft becomes law, Grapefruit customers throughout the country will be able to purchase either non-THC hemp derived Hourglass time-release CBD delivery cream or THC+cannabinoid Hourglass time-release full-spectrum delivery or any combination thereof as they desire. Furthermore, these superior, breakthrough Grapefruit Hourglass products are only available from Grapefruit or its authorized intermediaries. We believe passage of the ACT, as presented in the discussion draft, will be profoundly beneficial to Grapefruit and its shareholders, as well as to the American public.”

To view the full press release, visit https://ibn.fm/UPz3v

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.